Axi Select Expands Pro M Ranks to 10 as Global Trader Community Surpasses 49,000

Axi Select Expands Pro M Ranks to 10 as Global Trader Community Surpasses 49,000 GlobeNewswire January 27, 2026 SYDNEY, Jan. 27, 2026 (GLOBE NEWSWIRE) — Leading online FX and CFD broker Axi has shared that 10 traders worldwide have now reached the $1M Pro M level in Axi Select – the broker's flagship capital allocation […]

Evestia Clinical Acquires ICRC-Weyer to Enhance Global Full-Service Clinical Research Capabilities

Evestia Clinical Acquires ICRC-Weyer to Enhance Global Full-Service Clinical Research Capabilities GlobeNewswire January 27, 2026 Acquisition adds further specialist biostatistics, data management, and medical writing expertise to Evestia Clinical's full-service offering and strengthens its presence in Germany and across Europe LONDON, Jan. 27, 2026 (GLOBE NEWSWIRE) — Evestia Clinical (“the Company” or “the Group”), a

C12 and Classiq Partner to Accelerate Access to Spin Qubit Quantum Computing

C12 and Classiq Partner to Accelerate Access to Spin Qubit Quantum Computing GlobeNewswire January 27, 2026 PARIS and TEL AVIV, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) — C12, a European deep-tech company building the next generation of spin qubit quantum processors, and Classiq, the leading software platform for enterprise-grade quantum computing development, today announced a

Feedzai Named a Leader in QKS Group’s 2025 SPARK Matrix(TM) as Financial Institutions Seek Unified, Real-Time Data Foundations for Compliance

Feedzai Named a Leader in QKS Group's 2025 SPARK Matrix(TM) as Financial Institutions Seek Unified, Real-Time Data Foundations for Compliance Global advisory firm recognizes Feedzai for technology excellence and customer impact in financial crime data management GlobeNewswire January 27, 2026 Pune, India, Jan. 27, 2026 (GLOBE NEWSWIRE) — Global advisory firm QKS Group has named

SweetWater 420 Fest Unveils Powerhouse 2026 Lineup: Umphrey’s McGee, Thievery Corporation & Chromeo to Headline

SweetWater 420 Fest Unveils Powerhouse 2026 Lineup: Umphrey's McGee, Thievery Corporation & Chromeo to Headline April 17-18: SweetWater's Biggest Music Festival Returns–Tickets on Sale Now GlobeNewswire January 27, 2026 ATLANTA, Jan. 27, 2026 (GLOBE NEWSWIRE) — SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the leading craft beer brand in the Southeast by Tilray Brands, Inc.

Power Rental Market worth $15.05 billion by 2030 | MarketsandMarkets(TM)

According to MarketsandMarkets(TM), the global Power Rental Market size is projected to grow from USD 11.44 billion in 2025 to USD 15.05 billion by 2030 at a compound annual growth rate (CAGR) of 5.6% during the forecast period. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg Browse 200 market data Tables and 60 Figures spread through 300 Pages and in-depth TOC on

Invesco Reports Results for the Three Months and Year Ended December 31, 2025

Invesco Announces Fourth Quarter Diluted EPS of $(2.61); Adjusted Diluted EPS(1) of $0.62 A non-cash intangible impairment of $1.8 billion negatively impacted Fourth Quarter Diluted EPS by $3.01 Invesco Ltd. (NYSE: IVZ) today reported financial results for the three months and year ended December 31, 2025. — $19.1 billion of net long-term inflows for the

RTX Reports 2025 Results and Announces 2026 Outlook

RTX delivers strong 2025 sales, EPS, and free cash flow;* Expects continued sales, earnings, and cash flow growth in 2026 RTX (NYSE: RTX) reports fourth quarter and full year 2025 results, and announces 2026 outlook. Fourth quarter 2025 — Sales of $24.2 billion, up 12 percent versus prior year, and up 14 percent organically* —

Roper Technologies announces 2025 financial results

(NASDAQ:ROP), SARASOTA, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) — Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth quarter 2025 highlights Revenue increased 10% to $2.06 billion; acquisition contribution was +5% and organic revenue was +4% GAAP net earnings decreased 7% to $428 million;

Aclaris Therapeutics’ Novel ITK/JAK3 Inhibitor ATI-2138 Demonstrates Rapid and Sustained Hair Regrowth in Validated Murine Model of Alopecia Areata (AA)

(NASDAQ:ACRS), – ATI-2138 Outperforms Ritlecitinib in Reversal Model of Alopecia Universalis, the Most Severe AA Phenotype – WAYNE, Pa., Jan. 27, 2026 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced recent positive preclinical results from its potent and selective ITK/JAK3

Scroll to Top